(Yicai) Nov. 26 -- Sinovac Biotech has signed a USD700 million vaccine supply agreement with Brazil’s health ministry, ...

BEIJING--(BUSINESS WIRE)-- Sinovac Biotech Ltd. (“SINOVAC” or the “Company”) (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, today kicked off the enrollment for a Phase III ...

Sinovac Biotech (SVA) kicked off the enrollment for a Phase III clinical trial on a vaccine candidate to prevent HFMD caused by both Enterovirus 71 and Coxsackievirus 16. Notably, no multivalent ...

HONG KONG (Reuters) – Hong Kong has formally approved China’s Sinovac vaccine for emergency use with the rollout starting on Feb. 26, the city’s health secretary said on Thursday, paving the way for ...

BEIJING, Sept 24 (Reuters) - China's Sinovac Biotech expects to begin analysing final-stage human trial data on its coronavirus vaccine candidate this year to decide whether it is effective enough to ...

Washington, D.C. – The U.S. Defense Department admitted it spread propaganda in the Philippines aimed at disparaging China’s Sinovac vaccine during the COVID-19 pandemic, according to a June 25 ...

SINOVAC was the first company to be granted approval for its H1N1 influenza vaccine Panflu.1®, which has supplied the Chinese government's vaccination campaign and stockpiling program. The Company is ...

TAIPEI, Taiwan (AP) — China has given broader approval for the domestic-made Sinovac coronavirus vaccine, expanding those who can receive it beyond the high-risk and priority groups already allowed ...

Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, today announced that the Company has obtained approval to begin human clinical trials on its Sabin ...

SERRANA, Brazil, Feb 17 (Reuters) - The COVID-19 vaccine developed by China’s Sinovac Biotech (SVA.O), opens new tab is effective against the UK and South African variants, the vaccine's Brazilian ...

COVAX has signed agreements with two Chinese pharmaceutical companies to buy more than half a billion of their Covid-19 vaccines by the first half of next year, Global Alliance for Vaccines and ...